Gsk (GSK) Receivables (2009 - 2026)
Gsk (GSK) posted quarterly Receivables of $10.3 billion for Q2 2026, up 5.86% year-over-year from $9.8 billion in Q2 2025, and down 1.12% quarter-over-quarter from $10.5 billion in Q1 2026.
Gsk (GSK) Receivables (2009 - 2026) Analysis & Trends
Gsk's Receivables history runs 18 years deep, the most recent figure standing at $10.3 billion for Q2 2026.
- In Q2 2026, Receivables rose 5.86% year-over-year to $10.3 billion; the TTM figure through Jun 2026 stood at $10.3 billion (up 5.86% YoY), while the FY2025 annual figure was $11.4 billion, up 15.55% from the prior year.
- Receivables for Q2 2026 stood at $10.3 billion, down from $10.5 billion in the prior quarter.
- The five-year high for Receivables was $18.4 billion in Q1 2022, with the low at $8.1 billion in Q2 2022.
- The 5-year median for Receivables is $9.7 billion (2025), against an average of $10.1 billion.
- The sharpest annual moves came in 2022 and 2023: Receivables soared 106.03% in 2022, then plunged 54.97% in 2023.
- Gsk's Receivables stood at $9.7 billion in 2022, then climbed by 7.75% to $10.5 billion in 2023, then decreased by 5.63% to $9.9 billion in 2024, then increased by 16.1% to $11.5 billion in 2025, then slipped by 9.81% to $10.3 billion in 2026.
- Business Quant data shows GSK's Receivables at $10.3 billion in Q2 2026, $10.5 billion in Q1 2026, and $11.5 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 14.33 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 5.90 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 10.34 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 10.13 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.34 Bn |
| Mar 31, 2026 | 10.46 Bn |
| Dec 31, 2025 | 11.46 Bn |
| Sep 30, 2025 | 10.71 Bn |
| Jun 30, 2025 | 9.77 Bn |
| Mar 31, 2025 | 8.89 Bn |
| Dec 31, 2024 | 9.87 Bn |
| Sep 30, 2024 | 9.59 Bn |
| Jun 30, 2024 | 9.16 Bn |
| Mar 31, 2024 | 8.67 Bn |
| Dec 31, 2023 | 10.46 Bn |
| Sep 30, 2023 | 10.82 Bn |
| Jun 30, 2023 | 8.48 Bn |
| Mar 31, 2023 | 8.31 Bn |
| Dec 31, 2022 | 9.71 Bn |
| Sep 30, 2022 | 8.85 Bn |
| Jun 30, 2022 | 8.13 Bn |
| Mar 31, 2022 | 18.44 Bn |
| Dec 31, 2021 | 12.30 Bn |
| Sep 30, 2021 | 10.61 Bn |